TELO
Telomir Pharmaceuticals
$1.23
+$0.08 (+6.96%)Jul 27, 2026
Key metrics
The numbers that frame TELO today
- Market cap
- $84.59M
- P/E (TTM)
- -9.2
- EV / FCF
- -17.2
- ROIC
- 1,542.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.89
- 52wk High
- $2.32
Growth
Revenue and earnings trend for TELO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TELO
Is Telomir Pharmaceuticals a good buy?
No. Telomir Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Telomir Pharmaceuticals is selling at a high price.
What is the market capitalization of TELO?
Telomir Pharmaceuticals's market capitalization is $84.59M.
What is the P/E ratio for TELO stock?
Telomir Pharmaceuticals's current P/E ratio is -9.2.
What is the 52-week high for TELO stock?
The 52-week high for Telomir Pharmaceuticals is $2.32. The current close of $1.23 is 47% below that high.
What is the 52-week low for TELO stock?
The 52-week low for Telomir Pharmaceuticals is $0.89. The current close of $1.23 is 38.5% above that low.
Does TELO stock pay dividends?
Telomir Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TELO?
Telomir Pharmaceuticals's Debt / Equity ratio is 0.04.